Vitamin E in cell signaling.

[1]  J. Neuzil,et al.  The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease. , 2001, Atherosclerosis.

[2]  S. Devaraj,et al.  α-Tocopherol decreases CD36 expression in human monocyte-derived macrophages , 2001 .

[3]  S. Yusuf,et al.  Effects of Ramipril and Vitamin E on Atherosclerosis: The Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE) , 2001, Circulation.

[4]  S. Devaraj,et al.  The Effect of α-Tocopherol on Monocyte Proatherogenic Activity , 2001 .

[5]  G. Rimbach,et al.  Molecular Aspects of α-Tocotrienol Antioxidant Action and Cell Signalling , 2001 .

[6]  S. Meydani,et al.  Vitamin E and macrophage cyclooxygenase regulation in the aged. , 2001, The Journal of nutrition.

[7]  K. Jishage,et al.  α-Tocopherol Transfer Protein Is Important for the Normal Development of Placental Labyrinthine Trophoblasts in Mice* , 2001, Journal of Biological Chemistry.

[8]  T. Lakka,et al.  Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3‐year progression of carotid atherosclerosis , 2000, Journal of internal medicine.

[9]  M. Boaz,et al.  Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial , 2000, The Lancet.

[10]  A. Stocker,et al.  A Novel Human Tocopherol-associated Protein , 2000, The Journal of Biological Chemistry.

[11]  A. Azzi,et al.  Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. , 2000, Circulation.

[12]  S. Grundy,et al.  Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. , 2000, Atherosclerosis.

[13]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[14]  F. Violi,et al.  Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque : effect of vitamin E supplementation. , 2000, Circulation.

[15]  Bordone,et al.  DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. I. CORRELATION WITH PLASMA ANTIOXIDANT LEVELS AND COMPOSITION OF LIPOPROTEINS. , 2000, Pharmacological research.

[16]  Dayong Wu,et al.  Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. , 1999, Atherosclerosis.

[17]  C. Rice-Evans,et al.  Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation. , 1999, Atherosclerosis.

[18]  B. Shukitt-Hale,et al.  Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations , 1999, Brain Research.

[19]  Jawahar L. Mehta,et al.  Differential effects of α- and γ-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis , 1999 .

[20]  A. Azzi,et al.  Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. , 1999, Free radical biology & medicine.

[21]  G. King,et al.  d-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. , 1999, Diabetes research and clinical practice.

[22]  R. Marchioli.  Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. , 1999, Pharmacological research.

[23]  Morris J. Brown.  Do vitamin E and fish oil protect against ischaemic heart disease? , 1999, The Lancet.

[24]  A. Stocker,et al.  Identification of a Novel Cytosolic Tocopherol‐Binding Protein: Structure, Specificity, and Tissue Distribution , 1999, IUBMB life.

[25]  J. Freedman,et al.  Vitamin E and vascular homeostasis: implications for atherosclerosis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  D. Teupser,et al.  Alpha-tocopherol down-regulates scavenger receptor activity in macrophages. , 1999, Atherosclerosis.

[27]  D. Teupser,et al.  Scavenger receptor activity is increased in macrophages from rabbits with low atherosclerotic response: studies in normocholesterolemic high and low atherosclerotic response rabbits. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[28]  T. Wisniewski,et al.  Localization of α-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders , 1999, Brain Research.

[29]  A. Azzi,et al.  Modulation of α‐tropomyosin expression by α‐tocopherol in rat vascular smooth muscle cells , 1999 .

[30]  N. Bouslam,et al.  Vitamin E deficiency ataxia associated with adenoma , 1999, Journal of the Neurological Sciences.

[31]  C. Léger,et al.  alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. , 1998, The Journal of biological chemistry.

[32]  H. Shaw,et al.  Liver alpha-tocopherol transfer protein and its mRNA are differentially altered by dietary vitamin E deficiency and protein insufficiency in rats. , 1998, The Journal of nutrition.

[33]  S. Devaraj,et al.  α-Tocopherol Enrichment of Monocytes Decreases Agonist-Induced Adhesion to Human Endothelial Cells , 1998 .

[34]  D. Rader,et al.  Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice , 1998, Nature Medicine.

[35]  S. Clément,et al.  alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. , 1998, The Biochemical journal.

[36]  S. Ripatti,et al.  Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. , 1998, Journal of the National Cancer Institute.

[37]  S. Devaraj,et al.  The effects of alpha-tocopherol on critical cells in atherogenesis. , 1998, Current opinion in lipidology.

[38]  T. Yoshikawa,et al.  α‐tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells , 1998 .

[39]  M. Karin,et al.  Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase , 1997, Molecular and cellular biology.

[40]  B. Adams-Huet,et al.  Dose-Response Comparison of RRR-α-Tocopherol and All-Racemic α-Tocopherol on LDL Oxidation , 1997 .

[41]  A. Anagnostou,et al.  Dl‐alpha‐tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro‐ and megakaryoblastic leukemia cells , 1997, Journal of cellular physiology.

[42]  F. DeRubertis,et al.  Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. , 1997, Metabolism: clinical and experimental.

[43]  H. Ito,et al.  α-Tocopherol transfer protein gene: Exon skipping of all transcripts causes ataxia , 1997, Neurology.

[44]  G. Ferns,et al.  Dietary vitamin E supplementation inhibits thrombin‐induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercholesterolaemia , 1997, International journal of experimental pathology.

[45]  H. Tada,et al.  Protective effect of D-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations. , 1997, Metabolism: clinical and experimental.

[46]  S. Clément,et al.  The effect of alpha-tocopherol on the synthesis, phosphorylation and activity of protein kinase C in smooth muscle cells after phorbol 12-myristate 13-acetate down-regulation. , 1997, European journal of biochemistry.

[47]  M. Kiyosawa,et al.  Friedreich‐like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the α‐Tocopherol transfer protein gene , 1997, Annals of neurology.

[48]  P. Reitsma,et al.  Correlation of repressed transcription of α‐tocopherol transfer protein with serum α‐tocopherol during hepatocarcinogenesis , 1997 .

[49]  J. Blumberg,et al.  Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[50]  G. King,et al.  Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. , 1997, Journal of the American Society of Nephrology : JASN.

[51]  M. Hayn,et al.  Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. , 1997, Advances in pharmacology.

[52]  A. Anagnostou,et al.  dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. , 1997, Nutrition and cancer.

[53]  P. Touboul,et al.  Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Artériel. , 1997, The American journal of clinical nutrition.

[54]  C. H. Liu,et al.  Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. , 1996, Circulation.

[55]  J. Loscalzo,et al.  alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. , 1996, Circulation.

[56]  J. Palmgren,et al.  Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. , 1996, Journal of the National Cancer Institute.

[57]  W. Mack,et al.  Carotid intima-media thickness as a surrogate end point for coronary artery disease. , 1996, Circulation.

[58]  S. Devaraj,et al.  The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. , 1996, The Journal of clinical investigation.

[59]  M. Eichholzer,et al.  Prediction of male cancer mortality by plasma levels of interacting vitamins: 17‐year follow‐up of the prospective Basel study , 1996, International journal of cancer.

[60]  F. Kelly,et al.  Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) , 1996, The Lancet.

[61]  S. Devaraj,et al.  Oxidized low-density lipoprotein and atherosclerosis , 1996, International journal of clinical & laboratory research.

[62]  A. Azzi,et al.  d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Azzi,et al.  Vitamin E: a sensor and an information transducer of the cell oxidation state. , 1995, The American journal of clinical nutrition.

[64]  T. Utsumi,et al.  Inhibition of stimulus-specific neutrophil superoxide generation by alpha-tocopherol. , 1995, Free radical research.

[65]  R H Selzer,et al.  Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. , 1994, Atherosclerosis.

[66]  G. Gyapay,et al.  Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping , 1993, Nature genetics.

[67]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[68]  W. Pryor,et al.  A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants , 1993 .

[69]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[70]  H. Stähelin,et al.  Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. , 1993, The American journal of clinical nutrition.

[71]  L. Packer,et al.  Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. , 1993, Biochimica et biophysica acta.

[72]  E. Chatelain,et al.  d-α-tocopherol control of cell proliferation , 1993 .

[73]  C. Hensey,et al.  The protein kinase C family. , 1992, European journal of biochemistry.

[74]  A. Szewczyk,et al.  Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. , 1991, The Journal of biological chemistry.

[75]  A. Szewczyk,et al.  α-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity , 1991 .

[76]  R. L. Johnson,et al.  The Cholesterol Lowering Atherosclerosis Study (CLAS): design, methods, and baseline results. , 1987, Controlled clinical trials.